Combination of SIRT1 and Src overexpression suggests poor prognosis in luminal breast cancer
OncoTargets and Therapy Apr 18, 2018
Tan J, et al. - Researchers intended to analyze the correlation of SIRT1 and Src with human breast cancer (BC) prognosis. They also explored the roles of SIRT1 and Src in BC cell proliferation, tumor invasion, and metastasis; and assessed the correlation and interaction between SIRT1 and Src. SIRT1 and Src overexpression, both, showed a correlation with poor prognosis in human BC. For luminal-type BC, SIRT1 + Src (SIRT1 and/or Src positivity) was acknowledged as a fine prognosis model. In BC migration and invasion, but not in cell proliferation, SIRT1 was found to be a copromotor of Src. A potential interaction or a common regulation pathway was suggested between SIRT1 and Src expression and activity.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries